Literature DB >> 17374083

Animal models--what they can tell us about vascular calcification in CKD.

Ziad A Massy1, Michel Slama, Christophe Tribouilloy, Tilman B Drüeke.   

Abstract

The development of cardiovascular calcifications in chronic kidney disease (CKD) patients involves multiple risk factors with additive effects. However, a number of questions concerning cardiovascular calcifications in CKD patients remain unanswered at present due to lack of clinical data or due to the impossibility of conducting clinical trials to investigate these issues. In this review, we discuss how animal models could help us understand better the pathophysiology and management of calcifying cardiovascular complications associated with CKD.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17374083     DOI: 10.1111/j.1525-139X.2007.00256.x

Source DB:  PubMed          Journal:  Semin Dial        ISSN: 0894-0959            Impact factor:   3.455


  4 in total

1.  A Reproducible Mouse Model of Moderate CKD With Early Manifestations of Osteoblastic Transition of Cardiovascular System.

Authors:  Sarah E Machado; Daryll Spangler; Laurence M Black; Amie M Traylor; József Balla; Abolfazl Zarjou
Journal:  Front Physiol       Date:  2022-04-29       Impact factor: 4.755

2.  Development of a novel chronic kidney disease mouse model to evaluate the progression of hyperphosphatemia and associated mineral bone disease.

Authors:  Takashi Tani; Hideo Orimo; Akira Shimizu; Shuichi Tsuruoka
Journal:  Sci Rep       Date:  2017-05-22       Impact factor: 4.379

3.  The Pharmacological Effect and Mechanism of Lanthanum Hydroxide on Vascular Calcification Caused by Chronic Renal Failure Hyperphosphatemia.

Authors:  Lulu Zhao; Shengnan Wang; Hong Liu; Xiaoli Du; Ren Bu; Bing Li; Ruilan Han; Jie Gao; Yang Liu; Jian Hao; Jianrong Zhao; Yan Meng; Gang Li
Journal:  Front Cell Dev Biol       Date:  2021-04-13

4.  A novel model of adenine-induced tubulointerstitial nephropathy in mice.

Authors:  Ting Jia; Hannes Olauson; Karolina Lindberg; Risul Amin; Karin Edvardsson; Bengt Lindholm; Göran Andersson; Annika Wernerson; Yves Sabbagh; Susan Schiavi; Tobias E Larsson
Journal:  BMC Nephrol       Date:  2013-05-30       Impact factor: 2.388

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.